Article Information
History
- January 28, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Xuben Yu1,
- Chunhong Zhang1,
- Jingye Pan1,
- Ying Dai1,
- Ziye Zhou1,
- Fan Yang3,
- Ruolan Sun3,
- Yexuan Wang3,
- Yancheng Cao3,
- Changcheng Sheng4,
- Zheng Jiao2,* and
- Guanyang Lin1,*
- 1Department of Pharmacy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- 2Department of Pharmacy, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
- 3Department of Pharmacy, Wenzhou Medical University, Wenzhou, China
- 4Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China
- ↵*Corresponding author: Address correspondence to: Guanyang Lin and Zheng Jiao, Tel: +86-577-55578706, Fax: +86-557-55578706, E-mail: 13867702133{at}163.com to G.L., jiaozhen128{at}hotmail.com to Z.J.
X.Y., C.Z. and J.P. contributed equally to this work.
Posted January 28, 2020.
A reappraisal of polymyxin B dosing based on population pharmacokinetic model in patient with renal insufficiency
